USPA Global Announces Strategic Broadcast Association With Star Sports, Reaching Millions of Polo Sports Fans Across India

Share

WEST PALM BEACH, FL AND MUMBAI, INDIA / ACCESSWIRE / October 22, 2024 / USPA Global, the company that manages the multi-billion-dollar U.S. Polo Assn. brand, is proud to announce a landmark, multi-year broadcasting association with Star Sports, India's leading sports network and part of Disney's family of networks. This partnership is part of USPA Global's broadcasting subsidiary, Global Polo Entertainment (GPE), and launched in October.

U.S. Polo Assn.
U.S. Polo Assn.

This strategic association marks an innovative collaboration intended to bring polo sport content and the iconic U.S. Polo Assn. brand to engaged sports and brand fans in the very important and growing Indian market. This collaboration brings the thrilling world of polo directly to millions of homes across the Indian subcontinent, including India, Bangladesh, Bhutan, Maldives, Nepal, and Sri Lanka. The sport of polo will now reach even more viewers around the world, adding to current partnerships with ESPN and beIN Sports.

"Joining forces with Star Sports represents a significant step in our U.S. Polo Assn. market strategy to authentically engage with sports fans and consumers in one of our fastest growing and largest markets," said J. Michael Prince, President and CEO of USPA Global. "As the number one men's casualwear brand in India, U.S. Polo Assn. already has a strong presence with consumers, and this partnership will now build that same relationship across the Indian market with our mission to promote the sport of polo globally."

The Star Sports association begins the season with the award-winning series, Breakaway, a story-driven program where fans can see episodes covering the most prestigious tournaments, women's polo, and polo in England. Each episode will spotlight notable figures, such as U.S. Polo Assn.'s Global Brand Ambassador His Highness Maharaja Sawai Padmanabh Singh (Pacho) of Jaipur along with Indian Polo and the Jaipur Team, as well as world-renowned players such as Hope Arellano, Adolfo Cambiaso, Jeta Castagnola, and many more.

"As the brand licensee of U.S. Polo Assn. in India, Arvind Fashions is incredibly proud to be part of this partnership that is bringing such exciting sports entertainment to our consumers and all sports fans in India," said Shailesh Chaturvedi, CEO & Managing Director of Arvind Fashions Ltd., U.S. Polo Assn.'s Strategic Partner. "Making further inroads into sports in India is a significant step in the history of the U.S. Polo Assn. brand and what makes this market-leading brand truly authentic."

By aligning with Star Sports, U.S. Polo Assn. is now part of the multi-sport environment in the Indian sports broadcasting scene. The network's extensive coverage includes premier sporting events such as cricket with Tata India Premier League (IPL), Premier League Football, and Wimbledon.

"Embracing the sport of polo as part of our diverse sports culture aligns perfectly with our mission to expand our sports offerings and engage with a broader audience," said Harry Griffith, Head of Acquisition and Syndication at Star Sports. "We are excited to introduce our viewers to the rich history and dynamic action of polo through our collaboration with USPA Global and the U.S. Polo Assn. brand."

About U.S. Polo Assn. and USPA Global

U.S. Polo Assn. is the official brand of the United States Polo Association (USPA), the governing body for the sport of polo in the United States and one of the country's oldest sports governing bodies, founded in 1890. With a multi-billion-dollar global footprint and worldwide distribution through more than 1,100 U.S. Polo Assn. retail stores as well as thousands of additional points of distribution, U.S. Polo Assn. offers apparel, accessories, and footwear for men, women, and children in more than 190 countries worldwide. A historic, multi-year deal with ESPN to broadcast several of the premier polo championships in the world, sponsored by U.S. Polo Assn., has made the thrilling sport accessible to millions of sports fans globally for the very first time.

U.S. Polo Assn. has consistently been named one of the top global sports licensors in the world alongside the NFL, NBA, and MLB, according to License Global. In addition, the sport-inspired brand is being recognized internationally with awards for global and digital growth. Due to its tremendous success as a global brand, U.S. Polo Assn. has been featured in Forbes, Fortune, Modern Retail, and GQ as well as on Yahoo Finance and Bloomberg, among many other noteworthy media sources around the world.

For more information, visit uspoloassnglobal.com and uspashop.com, and follow @uspoloassn. 

USPA Global is a subsidiary of the USPA and manages the global, multi-billion-dollar U.S. Polo Assn. brand. Through its subsidiary, Global Polo Entertainment (GPE), USPA Global also manages Global Polo TV, which provides sports and lifestyle content. For more sports content, visit globalpolo.com.

About Star Sports

The Star Sports Network is home to several leading domestic and international sports with seventeen channels broadcasting premier sporting events which include cricket coverage under the purview of the TATA Indian Premier League (IPL), International Cricket Council (ICC), Cricket South Africa and Cricket Australia; Kabaddi under Pro Kabaddi League; and premier sports with Premier League; and Wimbledon amongst others.

Contact Information

Shannon Stilson
VP, Sports Marketing & Media
sstilson@uspagl.com
+001.561.227.6994

Stacey Kovalsky
Senior Director, Global Communications
skovalsky@uspagl.com
+001.561.790.8036

Rohan D'souza
Star Sports PR
rohan.dsouza@disney.com
+91 9833834146

SOURCE: USPA Global Licensing Inc.

View the original press release on newswire.com.

USPA Global

Subscribe to releases from Accesswire

Subscribe to all the latest releases from Accesswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Accesswire

VisiRose Introduces Revolutionary Therapy for Severe Eye Infections10.12.2024 07:30:00 CET | Press Release

Collaboration between Bascom Palmer Eye Institute and Provectus Biopharmaceuticals KNOXVILLE, TN / ACCESSWIRE / December 10, 2024 / VisiRose, a clinical-stage biotechnology company, is introducing Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT), a groundbreaking, non-invasive investigational treatment for infectious keratitis and other serious eye infections developed by the University of Miami Miller School of Medicine's Bascom Palmer Eye Institute (BPEI). VisiRose, a newly launched company of Provectus Biopharmaceuticals (OTCQB:PVCT) and the University, is focused on commercializing this innovative ocular research by combining a formulation of Provectus's pharmaceutical-grade bioactive synthetic small molecule Rose Bengal Sodium (RBS) and BPEI's light-based medical device to treat eye infections caused by bacteria, fungi, and parasites. RB PDAT offers a potential solution to the growing global problem of antimicrobial resistance (AMR), providing a broad-spectrum ocular thera

Young Girl Discovers a 3,500-year-old Egyptian Amulet9.12.2024 07:40:00 CET | Press Release

During a family trip near an archaeological site in Hod Hasharon, 12-year-old Dafna Filshteiner found an ancient scarab. LONDON, UK / ACCESSWIRE / December 9, 2024 / Dafna Filshteiner, age 12, was recently hiking below the ancient site of Tel Qana in Hod Hasharon, when suddenly, to her surprise, she discovered an unusual find a beetle-like stone used as an Egyptian amulet about 3,500 years ago. "I was looking down at the ground to find porcupine needles and smooth pebbles," she says. "And suddenly I picked up an interesting stone. I showed it to my mother, and she said it was just an ordinary stone or a bead. But then I saw a decoration and stubbornly insisted it was more than that, so we searched on the Internet. There, we identified more photos of stones similar to what we had found. We realized that it was something special and immediately called the Antiquities Authority." The family turned to Mor Wiesel, an archaeologist at the Israel Antiquities Authority, who thanked Dafna and h

Loar Announces Launch of Public Offering9.12.2024 06:30:00 CET | Press Release

WHITE PLAINS, NY / ACCESSWIRE / December 9, 2024 / Loar Holdings Inc. (NYSE:LOAR) ("Loar") announced today that it has launched the roadshow for the public offering of 4,750,000 shares of its common stock, including 1,583,333 shares offered by certain stockholders and 3,166,667 shares offered by Loar. In addition, such selling stockholders expect to grant the underwriters a 30-day option to purchase up to 712,500 additional shares of common stock at the public offering price, less underwriting discounts and commissions. Loar intends to use the net proceeds from this offering for repayment of borrowings outstanding under its credit agreement and, to the extent of any remaining proceeds, for general corporate purposes, including working capital. Loar will not receive any of the proceeds from the sale of common stock offered by the selling stockholders, including any common stock sold pursuant to any exercise by the underwriters of their option to purchase additional shares. Jefferies and

ProteinQure to Present Data on PQ203, a Novel Peptide-Drug Conjugate for Triple Negative Breast Cancer, at 2024 San Antonio Breast Cancer Symposium6.12.2024 12:30:00 CET | Press Release

TORONTO, ON / ACCESSWIRE / December 6, 2024 / ProteinQure, the leading company in computational design of peptide therapeutics, will be presenting compelling new data on the progress of their lead triple negative breast cancer (TNBC) drug PQ203 (December 12, 2024 presentation ID: P4-12-17) at the 2024 San Antonio Breast Cancer Symposium. PQ203 is a novel Peptide Drug Conjugate composed of a Sortilin receptor targeting peptide conjugated to the cytotoxic agent monomethyl auristatin E. The Sortiin receptor is expressed in a high percentage of diseased tissue from TNBC patients and as such represents an innovative treatment for this challenging sub-type of breast cancer. ProteinQure has recently generated data that PQ203 exhibits potent efficacy in a patient-derived xenograft (PDX) model resistant to Sacituzumab Govitecan (Trodelvy™), an antibody drug conjugate that is the emerging standard of care for metastatic TNBC. Additionally, PQ203 has shown an encouraging safety profile. Based on

CNS Pharmaceuticals to Host Virtual Analyst & Investor Day on December 11, 20245.12.2024 09:10:00 CET | Press Release

Live webcast discussion featuring internationally renowned Glioblastoma Multiforme (GBM) Key Opinion Leaders Company committed to addressing the most aggressive type of brain cancer with an average survival of only 14 to 16 months after diagnosis and no cure Register for the event here HOUSTON, TX / ACCESSWIRE / December 5, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced it will host a Virtual Analyst & Investor Day on Wednesday, December 11th from 11:30 AM - 1:00 PM ET. For the event, John Climaco, Chief Executive Officer, Sandra Silberman, MD, PhD, Chief Medical Officer and Zena Muzyczenko, Vice President of Clinical Operations at CNS Pharmaceuticals will be joined by Key Opinion Leaders: Michael Weller, Prof. Dr. med. Director of Department, Department of Neurology, Universitatsspital, Zur

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye